Envestnet Asset Management’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13M | Sell |
|
|||||
|
2025
Q1 | $33.3M | Sell |
|
|||||
|
2024
Q4 | $45.1M | Sell |
|
|||||
|
2024
Q3 | $56.3M | Sell |
|
|||||
|
2024
Q2 | $65.9M | Buy |
|
|||||
|
2024
Q1 | $83.4M | Buy |
|
|||||
|
2023
Q4 | $63.5M | Sell |
|
|||||
|
2023
Q3 | $52.7M | Buy |
|
|||||
|
2023
Q2 | $37.8M | Buy |
|
|||||
|
2023
Q1 | $33.5M | Buy |
|
|||||
|
2022
Q4 | $34.9M | Sell |
|
|||||
|
2022
Q3 | $32.2M | Buy |
|
|||||
|
2022
Q2 | $33.7M | Sell |
|
|||||
|
2022
Q1 | $45.8M | Buy |
|
|||||
|
2021
Q4 | $53M | Buy |
|
|||||
|
2021
Q3 | $52.7M | Buy |
|
|||||
|
2021
Q2 | $43.9M | Sell |
|
|||||
|
2021
Q1 | $39.5M | Buy |
|
|||||
|
2020
Q4 | $30.1M | Buy |
|
|||||
|
2020
Q3 | $25.8M | Buy |
|
|||||
|
2020
Q2 | $19M | Buy |
|
|||||
|
2020
Q1 | $13.4M | Buy |
|
|||||
|
2019
Q4 | $10.9M | Buy |
|
|||||
|
2019
Q3 | $9.36M | Buy |
|
|||||
|
2019
Q2 | $9.87M | Buy |
|
|||||
|
2019
Q1 | $8.37M | Buy |
|
|||||
|
2018
Q4 | $5.91M | Buy |
|
|||||
|
2018
Q3 | $946K | Sell |
|
|||||
|
2018
Q2 | $1.12M | Buy |
|
|||||
|
2018
Q1 | $220K | Sell |
|
|||||
|
2017
Q4 | $1.5M | Sell |
|
|||||
|
2017
Q3 | $1.5M | Buy |
|
|||||
|
2017
Q2 | $142K | Sell |
|
|||||
|
2017
Q1 | $156K | Sell |
|
|||||
|
2016
Q4 | $135K | Buy |
|
|||||
|
2016
Q3 | $105K | Sell |
|
|||||
|
2016
Q2 | $185K | Sell |
|
|||||
|
2016
Q1 | $205K | Sell |
|
|||||
|
2015
Q4 | $219K | Buy |
|
|||||
|
2015
Q3 | $163K | Buy |
|
|||||
|
2015
Q1 | – | Sell |
|
|||||
|
2014
Q4 | $19K | Sell |
|
|||||
|
2014
Q3 | $19K | Buy |
|
|||||
|
2014
Q2 | $13K | Buy |
|
|||||
|
2014
Q1 | $6K | Sell |
|
|||||
|
2013
Q4 | $8K | Sell |
|
|||||
|
2013
Q3 | $9K | Sell |
|
|||||
|
2013
Q2 | $11K | Buy |
|